Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Infect Dis (Lond) ; 52(3): 196-201, 2020 03.
Article in English | MEDLINE | ID: mdl-31778089

ABSTRACT

Introduction:Clostridium perfringens and other gas gangrene-forming clostridia are commensals of the human gut and vaginal microbiota, but can cause serious or even fatal infections. As there are relatively few published studies on antibiotic susceptibility of these bacteria, we decided to perform a 10-year retrospective study in a South-Eastern Hungarian clinical centre.Methods: A total of 372 gas gangrene-forming Clostridium spp. were isolated from clinically relevant samples and identified with rapid ID 32A (bioMérieux, France) and MALDI-TOF MS (Bruker Daltinics, Germany) methods. Antibiotic susceptibility was determined with E-tests.Results: We identified 313 C. perfringens, 20 C. septicum, 10 C. sordellii, 10 C. sporogenes, 9 C. tertium, 6 C. bifermentans, 4 C. histolyticum isolates. In C. perfringens isolates, the rate of penicillin resistance was 2.6% and the rate of clindamycin resistance 3.8%. Penicillin resistance was found in 6.8% and clindamycin resistance in 8.5% of the non-perfringens Clostridium spp. isolates.Conclusion: The antibiotic susceptibility of C. perfringens isolates was in good agreement with previous publications. The rates of resistance to penicillin and clindamycin were very low. The resistance rates of non-perfringens Clostridium spp. isolates were higher than those of C. perfringens strains, but lower than those published in the literature.


Subject(s)
Anti-Bacterial Agents/pharmacology , Clindamycin/pharmacology , Clostridium/drug effects , Gas Gangrene/microbiology , Penicillins/pharmacology , Adolescent , Adult , Aged , Aged, 80 and over , Amoxicillin-Potassium Clavulanate Combination/pharmacology , Cefoxitin/pharmacology , Child , Child, Preschool , Clostridium/isolation & purification , Clostridium bifermentans/drug effects , Clostridium bifermentans/isolation & purification , Clostridium histolyticum/drug effects , Clostridium histolyticum/isolation & purification , Clostridium perfringens/drug effects , Clostridium perfringens/isolation & purification , Clostridium septicum/drug effects , Clostridium septicum/isolation & purification , Clostridium sordellii/drug effects , Clostridium sordellii/isolation & purification , Clostridium tertium/drug effects , Clostridium tertium/isolation & purification , Drug Resistance, Bacterial , Female , Gas Gangrene/drug therapy , Humans , Hungary , Imipenem/pharmacology , Infant , Inhibitory Concentration 50 , Male , Meropenem/pharmacology , Microbial Sensitivity Tests , Middle Aged , Retrospective Studies , Tigecycline/pharmacology , Young Adult
2.
Mol Nutr Food Res ; 61(10)2017 10.
Article in English | MEDLINE | ID: mdl-28605130

ABSTRACT

SCOPE: To establish the role of cocoa theobromine on gut microbiota composition and fermentation products after cocoa consumption in rats. METHODS AND RESULTS: Lewis rats were fed either a standard diet (RF diet), a diet containing 10% cocoa (CC diet) or a diet including 0.25% theobromine (TB diet) for 15 days. Gut microbiota (fluorescence in situ hybridization coupled to flow cytometry and metagenomics analysis), SCFA and IgA-coated bacteria were analyzed in fecal samples. CC and TB diets induced lower counts of E. coli whereas TB diet led to lower counts of Bifidobacterium spp., Streptococcus spp. and Clostridium histolyticum-C. perfingens group compared to RF diet. Metagenomics analysis also revealed a different microbiota pattern among the studied groups. The SCFA content was higher after both CC and TB diets, which was mainly due to enhanced butyric acid production. Furthermore, both diets decreased the proportion of IgA-coated bacteria. CONCLUSION: Cocoa's theobromine plays a relevant role in some effects related to cocoa intake, such as the lower proportion of IgA-coated bacteria. Moreover, theobromine modifies gut microbiota although other cocoa compounds could also act on intestinal bacteria, attenuating or enhancing the theobromine effects.


Subject(s)
Cacao/chemistry , Gastrointestinal Microbiome/drug effects , Theobromine/pharmacology , Animals , Bifidobacterium/drug effects , Bifidobacterium/isolation & purification , Butyric Acid/metabolism , Clostridium histolyticum/drug effects , Clostridium histolyticum/isolation & purification , Colony Count, Microbial , DNA, Bacterial/genetics , Diet , Escherichia coli/drug effects , Escherichia coli/isolation & purification , Fatty Acids, Volatile/metabolism , Feces/microbiology , Fermentation , Immunoglobulin A/metabolism , In Situ Hybridization, Fluorescence , Lactic Acid/metabolism , Metagenomics , RNA, Ribosomal, 16S/genetics , Rats , Rats, Inbred Lew , Streptococcus/drug effects , Streptococcus/isolation & purification
3.
J Autism Dev Disord ; 47(2): 480-489, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27882443

ABSTRACT

There is an emerging body of evidence linking the intestinal microbiota with autism spectrum disorders (ASD). Studies have demonstrated differences in the composition of gut bacteria between children with ASD and controls. Certain intestinal bacteria have been observed in abundance and may be involved in the pathogenesis of ASD; including members of the Clostridium and Sutterella genus. Evidence from animal models suggest that certain microbial shifts in the gut may produce changes consistent with the clinical picture of autism, with proposed mechanisms including toxin production, aberrations in fermentation processes/products, and immunological and metabolic abnormalities. In this article, we review studies examining the relationship between intestinal bacteria and ASD, and discuss bacterial species that may be implicated and proposed mechanisms.


Subject(s)
Autistic Disorder/immunology , Autistic Disorder/microbiology , Gastrointestinal Absorption/immunology , Gastrointestinal Microbiome/immunology , Animals , Autism Spectrum Disorder/diagnosis , Autism Spectrum Disorder/immunology , Autism Spectrum Disorder/microbiology , Autistic Disorder/diagnosis , Child , Clostridium histolyticum/isolation & purification , Humans
4.
Rev. esp. cir. ortop. traumatol. (Ed. impr.) ; 57(6): 398-402, nov.-dic. 2013. tab, ilus
Article in Spanish | IBECS | ID: ibc-116866

ABSTRACT

Objetivo. La colagenasa del Clostridium histolyticum es una nueva opción terapéutica y el primer tratamiento farmacológico en el tratamiento de la enfermedad de Dupuytren. Material y métodos. Estudio prospectivo de 35 pacientes afectos de la enfermedad de Dupuytren. Se evaluó los resultados clínicos, funcionales, la satisfacción del paciente y la seguridad del fármaco. Resultados. Los resultados funcionales y clínicos tras su administración son buenos sobre todo en la articulación metacarpofalángica, con una recuperación rápida. El índice de contractura del dedo MCF previo a la punción fue de 64° y tras la punción de 4°; en las IFP previo a la punción fue de 83,3 grados y tras la punción de 15°; en MCF/IFP previo a la punción fue de 140° y tras la punción de 25°. Conclusiones. Es una alternativa de tratamiento de la enfermedad de Dupuytren, fundamentalmente en los ancianos. La investigación es necesaria para clarificar el índice de recurrencia de la enfermedad, las posibles reacciones adversas y comparar la eficacia y durabilidad con otras alternativas de tratamiento (AU)


Objective: The collagenase from Clostridium histolyticum is a new therapeutic option, and the first pharmacological one, in the treatment of Dupuytren’s disease. Material and methods: A prospective study was conducted on 35 patients with Dupuytren’s disease. The clinical and functional variables, as well as patient satisfaction and drug safety were evaluated. Results: The functional and clinical results after its administration were good, with a rapid recovery, especially at the metacarpophalangeal (MCP) joint. The index finger contracture prior to MCP puncture was 64 degrees and after puncture it was 4 degrees. In the proximal interphalangeal (PIP) prior to puncture it was 83.3 degrees and after puncture it was 15 degrees; In the MCP/PIP prior to puncture it was 140 degrees, and after puncture it 25 degrees. Conclusions: Collagenase from Clostridium histolyticum an alternative of treatment of Dupuytren’s disease, mainly in the elderly. More research is required in order to clarify the rate of recurrence of the disease, the possible adverse reactions, and to compare the efficiency and permanence with other treatment options (AU)


Subject(s)
Humans , Male , Female , Middle Aged , Dupuytren Contracture/diagnosis , Dupuytren Contracture/therapy , Clostridium histolyticum/isolation & purification , Patient Satisfaction/economics , Patient Satisfaction/statistics & numerical data , Risk Factors , Microbial Collagenase/therapeutic use , Prospective Studies , Patient Acceptance of Health Care , Patient Safety/standards , Surgical Wound Dehiscence/epidemiology , Surgical Wound Dehiscence/surgery
5.
Appl Microbiol Biotechnol ; 93(6): 2625-32, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21881890

ABSTRACT

The temporal and spatial distribution of the genus Bacillus and Clostridium histolyticum group in swine manure composting was determined by fluorescent in situ hybridization using fluorescently labeled 16S rRNA-targeted oligonucleotide probes LGC353b and Chis150, respectively. The temporal distribution of total bacteria, Bacillus and C. histolyticum, detected in each layer of the composting pile was noticeable in that the number of them detected at the high-temperature stage was higher than that of the cooling stage. The number detected at the cooling stage was higher than that of the temperature-rising stage. The number of the total bacteria distributed in three locations achieved balance at the stage of cooling. The spatial distribution of the genus Bacillus cells was that the number and the relative abundance of Bacillus cells detected in the middle layer of composting pile were the lowest at each stage of composting. However, the minimum value of the relative abundance exceeded 8%. Compared with Bacillus spp., the C. histolyticum group displayed higher relative abundance in the same layer at different stages of composting except in the top layer at the stage of high temperature. However, the characteristic of the spatial distribution was not noticeable. The detected limits of the genus Bacillus and C. histolyticum group were both found to be the high cell density of 10(6) cells g(-1) (wet weight). These results indicated that the genus Bacillus and C. histolyticum group were the predominant bacteria in the swine manure composting process and may play important role in this complex environment.


Subject(s)
Bacillus/isolation & purification , Clostridium histolyticum/isolation & purification , Manure/microbiology , Animals , Bacillus/genetics , Bacillus/metabolism , Biodegradation, Environmental , Clostridium histolyticum/genetics , Clostridium histolyticum/metabolism , In Situ Hybridization, Fluorescence , Manure/analysis , Swine
6.
Acta Paediatr ; 99(12): 1868-74, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20626364

ABSTRACT

AIM: Previously, glutamine-enriched enteral nutrition in very low birth weight infants (VLBW) decreased the incidence of atopic dermatitis at age 1 year. The aim of this study was to determine whether this effect is related to changes in intestinal bacterial species that are associated with allergy, such as bifidobacteria, clostridium histolyticum, clostridium lituseburense (Chis/lit group) and Escherichia coli at age 1 year. METHODS: Eighty-nine infants were eligible for this follow-up study, conducted at a Tertiary care hospital. Bifidobacteria, Chis/lit group and E. coli were measured by fluorescent in situ hybridization in faecal samples collected at age 1 year. Information on allergic and infectious diseases was previously determined by questionnaire. RESULTS: Seventy-two of 89 (81%) infants were participated. Prevalence of all studied species was not different between glutamine-supplemented and control groups. Allergic infants were less frequently colonized with bifidobacteria than nonallergic infants (p =0.04). Between neonatal period and 1 year, prevalence of bifidobacteria was increased (p < 0.001), of Chis/lit group was unchanged (p=0.84), and of E. coli was decreased (p < 0.001). CONCLUSION: The beneficial effect of glutamine-enriched enteral nutrition on the incidence of atopic dermatitis in the first year of life in VLBW infants is not related to changes in bifidobacteria, Chis/lit group or E. coli. Allergic VLBW infants are less frequently colonized with bifidobacteria compared to nonallergic VLBW infants.


Subject(s)
Dermatitis, Atopic/microbiology , Enteral Nutrition , Glutamine/administration & dosage , Infant Nutritional Physiological Phenomena , Infant, Very Low Birth Weight , Intestines/microbiology , Metagenome , Bifidobacterium/isolation & purification , Case-Control Studies , Clostridium/isolation & purification , Clostridium histolyticum/isolation & purification , Dermatitis, Atopic/epidemiology , Dietary Supplements , Escherichia coli/isolation & purification , Feces/microbiology , Female , Follow-Up Studies , Humans , Infant , Infant, Newborn , Male , Surveys and Questionnaires
7.
Scand J Infect Dis ; 40(10): 772-7, 2008.
Article in English | MEDLINE | ID: mdl-18609207

ABSTRACT

We aimed to evaluate broad-range PCR and subsequent sequencing compared to conventional culture in the diagnosis of spinal infection. The method was a prospective study of all patients admitted to Aarhus University Hospital for surgery during a 12-months period with a clinically diagnosed infection of the spine. Samples from patients undergoing surgery for non-infectious causes (malignancy etc.) were included as control group. Specimens were submitted to conventional culture and molecular investigation with 16S rRNA gene amplification and sequence analysis. 38 patients were included in the study (clinically diagnosed spinal infections=18; non-infectious diseases=20). The specificity was excellent for both culture and PCR (95% and 100%, respectively). A true culture positive result was obtained in 50% of patients (9/18) and 61% was positive (11/18) by broad-range PCR. When combined, culture and PCR allowed for a microbiological diagnosis in 72% of patients (13/18). A positive culture was found only in patients treated < or =7 d compared to < or =16 d for PCR. However, PCR and culture result were equally negatively affected by duration of treatment. The combination of culture and broad-range PCR substantially adds to the number of microbiological diagnoses obtained, and improves the clinician's opportunity to tailor therapy to individual patients.


Subject(s)
Bacterial Infections/microbiology , Epidural Abscess/microbiology , Osteitis/microbiology , Polymerase Chain Reaction/methods , Spinal Diseases/microbiology , Spondylitis/microbiology , Adult , Aged , Bacterial Infections/diagnosis , Case-Control Studies , Child, Preschool , Clostridium histolyticum/isolation & purification , Databases, Nucleic Acid , Discitis/diagnosis , Discitis/microbiology , Epidural Abscess/diagnosis , Female , Genes, Bacterial , Genes, rRNA , Humans , Kingella kingae/isolation & purification , Male , Middle Aged , Osteitis/diagnosis , Prospective Studies , Sequence Analysis, DNA , Spinal Diseases/diagnosis , Spondylitis/diagnosis , Staphylococcus aureus/isolation & purification
8.
J Anim Physiol Anim Nutr (Berl) ; 91(1-2): 48-53, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17217390

ABSTRACT

Inflammatory bowel disease (IBD) is a common cause of chronic large bowel diarrhoea in cats. Although the aetiology of IBD is unknown, an immune-mediated response to a luminal antigen is thought to be involved. As knowledge concerning the colonic microflora of cats is limited and requires further investigation, the purpose of this study was to determine the presence of specific bacterial groups in normal and IBD cats, and the potential role they play in the health of the host. Total bacterial populations, Bacteroides spp., Bifidobacterium spp., Clostridium histolyticum subgp., Lactobacillus-Enterococcus subgp. and Desulfovibrio spp. were enumerated in 34 healthy cats and 11 IBD cats using fluorescence in situ hybridisation. The study is one of the first to show the presence of Desulfovibrio in cats. Total bacteria, Bifidobacterium spp. and Bacteroides spp. counts were all significantly higher in healthy cats when compared with IBD cats, whereas Desulfovibrio spp. (producers of toxic sulphides) numbers were found to be significantly higher in colitic cats. The information obtained from this study suggests that modulation of bacterial flora by increasing bifidobacteria and decreasing Desulfovibrio spp. may be beneficial to cats with IBD. Dietary intervention may be an important aspect of their treatment.


Subject(s)
Bifidobacterium/isolation & purification , Cat Diseases/microbiology , Desulfovibrio/isolation & purification , Inflammatory Bowel Diseases/veterinary , Animals , Bacteroides/isolation & purification , Bifidobacterium/growth & development , Case-Control Studies , Cats , Clostridium histolyticum/isolation & purification , Colony Count, Microbial/veterinary , Desulfovibrio/growth & development , Feces/microbiology , In Situ Hybridization, Fluorescence/veterinary , Inflammatory Bowel Diseases/microbiology , Probiotics/therapeutic use
10.
J Med Microbiol ; 54(Pt 10): 987-991, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16157555

ABSTRACT

Children with autistic spectrum disorders (ASDs) tend to suffer from severe gastrointestinal problems. Such symptoms may be due to a disruption of the indigenous gut flora promoting the overgrowth of potentially pathogenic micro-organisms. The faecal flora of patients with ASDs was studied and compared with those of two control groups (healthy siblings and unrelated healthy children). Faecal bacterial populations were assessed through the use of a culture-independent technique, fluorescence in situ hybridization, using oligonucleotide probes targeting predominant components of the gut flora. The faecal flora of ASD patients contained a higher incidence of the Clostridium histolyticum group (Clostridium clusters I and II) of bacteria than that of healthy children. However, the non-autistic sibling group had an intermediate level of the C. histolyticum group, which was not significantly different from either of the other subject groups. Members of the C. histolyticum group are recognized toxin-producers and may contribute towards gut dysfunction, with their metabolic products also exerting systemic effects. Strategies to reduce clostridial population levels harboured by ASD patients or to improve their gut microflora profile through dietary modulation may help to alleviate gut disorders common in such patients.


Subject(s)
Autistic Disorder/microbiology , Bacteria/isolation & purification , Clostridium/isolation & purification , Feces/microbiology , Gastrointestinal Tract/microbiology , Child , Child, Preschool , Clostridium histolyticum/isolation & purification , Female , Humans , In Situ Hybridization, Fluorescence , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...